Limits...
Economic burden of asthma: a systematic review.

Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM - BMC Pulm Med (2009)

Bottom Line: It is also associated with the loss of future potential earnings related to both morbidity and mortality.Hospitalization and medications were found to be the most important cost driver of direct costs.Work and school loss accounted for the greatest percentage of indirect costs.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Clinical Epidemiology & Evaluation (C2E2), UBC, Vancouver, BC, Canada. Cbahadori@yahoo.ca

ABSTRACT

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.

Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.

Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.

Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Show MeSH

Related in: MedlinePlus

Trend in prevalence of asthma.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2698859&req=5

Figure 1: Trend in prevalence of asthma.

Mentions: Asthma is an inflammatory disorder of the lungs that affects people of all ages and is a significant source of morbidity and mortality worldwide [1,2]. Approximately 300 million people in the world currently have asthma and recent decades have shown a concerning increase in the prevalence of this condition in both children and adults (Figure 1). There has been concerning increase in the prevalence asthma in both children and adults) [3]. If the current trends continue, it is estimated that there may be an additional 100 million more asthmatics by 2025 [4].


Economic burden of asthma: a systematic review.

Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM - BMC Pulm Med (2009)

Trend in prevalence of asthma.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2698859&req=5

Figure 1: Trend in prevalence of asthma.
Mentions: Asthma is an inflammatory disorder of the lungs that affects people of all ages and is a significant source of morbidity and mortality worldwide [1,2]. Approximately 300 million people in the world currently have asthma and recent decades have shown a concerning increase in the prevalence of this condition in both children and adults (Figure 1). There has been concerning increase in the prevalence asthma in both children and adults) [3]. If the current trends continue, it is estimated that there may be an additional 100 million more asthmatics by 2025 [4].

Bottom Line: It is also associated with the loss of future potential earnings related to both morbidity and mortality.Hospitalization and medications were found to be the most important cost driver of direct costs.Work and school loss accounted for the greatest percentage of indirect costs.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Clinical Epidemiology & Evaluation (C2E2), UBC, Vancouver, BC, Canada. Cbahadori@yahoo.ca

ABSTRACT

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.

Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.

Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.

Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Show MeSH
Related in: MedlinePlus